Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;9(2):172-8.
doi: 10.1038/nmat2608. Epub 2009 Dec 13.

Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging

Affiliations

Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging

Patricia Horcajada et al. Nat Mater. 2010 Feb.

Abstract

In the domain of health, one important challenge is the efficient delivery of drugs in the body using non-toxic nanocarriers. Most of the existing carrier materials show poor drug loading (usually less than 5 wt% of the transported drug versus the carrier material) and/or rapid release of the proportion of the drug that is simply adsorbed (or anchored) at the external surface of the nanocarrier. In this context, porous hybrid solids, with the ability to tune their structures and porosities for better drug interactions and high loadings, are well suited to serve as nanocarriers for delivery and imaging applications. Here we show that specific non-toxic porous iron(III)-based metal-organic frameworks with engineered cores and surfaces, as well as imaging properties, function as superior nanocarriers for efficient controlled delivery of challenging antitumoural and retroviral drugs (that is, busulfan, azidothymidine triphosphate, doxorubicin or cidofovir) against cancer and AIDS. In addition to their high loadings, they also potentially associate therapeutics and diagnostics, thus opening the way for theranostics, or personalized patient treatments.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1989 May;86(10):3474-8 - PubMed
    1. J Am Chem Soc. 2008 Nov 5;130(44):14358-9 - PubMed
    1. Int J Pharm. 2006 Oct 31;324(1):37-42 - PubMed
    1. Cancer Chemother Pharmacol. 1989;24(6):386-90 - PubMed
    1. Clin Cancer Res. 2001 Feb;7(2):223-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources